Financials

  • Market Capitalization 23.73 M
  • Employee 40
  • Founded 2015
  • CEO N/A
  • Website www.nextcure.com
  • Headquarter Delaware, United States
  • FIGI BBG00BTH5153
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.72
Fiyat/satışlar oranı

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
4562
VYNE
VYNE Therapeutics Inc. - Common Stock
0.71 USD+7.58%+5.97%+9.23%-46.21%23.68 M USD
4565
NRSN
NeuroSense Therapeutics Ltd. - Ordinary Shares
0.72 USD-1.37%+5.88%-4.00%-64.00%23.44 M USD
4588
CELU
Celularity Inc. - Class A Common Stock
0.78 USD+2.63%+6.85%-2.50%-67.77%22.58 M USD
4595
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.45 USD-1.03%+2.67%-7.62%+129.91%21.77 M USD

Haberler